Furthermore, metformin can decrease the expression of pro-inflammatory cytokines including IL-1β and IL-6 regardless of diabetes status [215,216] and reduce levels of pro-inflammatory cytokines which result in increased bioavailability of serotonin through regulation of multiple pathways including the tryptophan/kynurenine system [217,218,219]. This evidence concerns the gene IL6 and diabetes mellitus.